Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists have transformed weight management, with clinical trials showing an average weight loss of 15–22% over 68 weeks in patients taking semaglutide. PlexusDx makes accessing these medications straightforward by eliminating insurance barriers and offering compounded formulations from licensed 503A pharmacies across all 50 states.
Understanding GLP-1 Medications for Weight Loss
GLP-1 receptor agonists mimic glucagon-like peptide-1, a hormone that regulates appetite and blood sugar. Semaglutide and tirzepatide are the two most studied compounds in this class, each working through your body's natural satiety pathways. Unlike older weight loss approaches, GLP-1 therapy addresses the hormonal mechanisms that drive hunger and calorie intake, making sustainable weight management more achievable.
Semaglutide was originally developed for type 2 diabetes but gained widespread attention for its weight loss effects in clinical populations. Tirzepatide, a newer dual-action compound, activates both GLP-1 and GIP receptors, potentially offering enhanced results. Both medications require a prescription and ongoing medical supervision, but PlexusDx streamlines the entire process from consultation to delivery.
Getting a GLP-1 Prescription Without Traditional Insurance
PlexusDx eliminates the insurance requirement by partnering directly with patients and licensed compounding pharmacies. The process begins with a telehealth consultation where a medical professional reviews your health history, current medications, and weight loss goals. This evaluation determines whether GLP-1 therapy is appropriate and which formulation—injection or oral—suits your lifestyle and preferences.
Unlike urgent care or primary care clinics that may not specialize in weight management, PlexusDx providers focus exclusively on precision GLP-1 therapy. Once your prescription is approved, medications ship directly to your home from licensed 503A compounding pharmacies. No membership fees, no insurance denials, and no out-of-network complications—PlexusDx pricing starts at $149 monthly for compounded semaglutide injection, with HSA and FSA eligibility available.
Choosing Between Semaglutide Injection and Oral Options
Semaglutide injections are administered once weekly and begin at $149 per month across PlexusDx's three commitment tiers. Oral semaglutide offers daily dosing for patients who prefer to avoid injections, starting at $249 monthly. Both formulations contain the same active ingredient and follow evidence-based dosing protocols; the choice depends on your comfort level and schedule.
Tirzepatide, the dual GLP-1/GIP receptor agonist, is available as a weekly injection starting at $249 monthly or as an oral formulation at $279 monthly. Some patients respond better to tirzepatide's dual mechanism, while others achieve their goals with semaglutide alone. PlexusDx's Precision Peptide Genetic Test can identify your genetic predispositions across 49 peptide pathways, including the GLP1R rs6923761 and GIPR rs1800437 variants, to help guide which compound may work best for your biology.
The PlexusDx Personalization Advantage
Personalized medicine goes beyond one-size-fits-all dosing. PlexusDx offers the Precision Peptide Genetic Test, a 99-dollar add-on after your first month of treatment, which analyzes 14 metabolic pathways and 150+ genetic insights. This test examines variants like FTO rs9939609 and MC4R rs17782313, which influence appetite regulation and metabolic rate, allowing your provider to optimize your specific therapeutic approach.
Genetic insights help PlexusDx providers anticipate how your body may respond to semaglutide or tirzepatide, potentially accelerating the time to your ideal dose and reducing trial-and-error adjustments. While your dose may need to increase over time, PlexusDx's pricing structure ensures your cost remains flat—your dose may go up, but your price won't. This transparency removes cost anxiety from the weight loss journey.
What to Expect During Your First Month on GLP-1
Your first dose is typically started at the lowest available strength to allow your body to adapt and minimize side effects. Most patients begin feeling reduced appetite within 2–5 days of their first injection, though full effects develop over 2–4 weeks as the medication accumulates in your system. Common initial experiences include mild nausea, changes in food preferences, and reduced portion sizes—sensations that usually fade as your body adjusts.
PlexusDx provides detailed guidance on injection technique, timing, and storage so you feel confident managing your medication at home. Your provider schedules check-ins to monitor your progress, side effect profile, and whether dose adjustments are needed. Most patients remain on a stable dose after 8–12 weeks, at which point weight loss becomes more predictable and manageable.
Costs, Eligibility, and Payment Options
PlexusDx compounded semaglutide injection starts at $149 monthly with no membership or insurance requirement. Tirzepatide injections begin at $249 monthly, while the Microdose GLP-1 Protocol offers the most affordable entry point at $129 monthly for patients exploring whether GLP-1 therapy suits them. All medications are HSA and FSA eligible, meaning you can use pre-tax health savings dollars to reduce out-of-pocket costs.
Pricing remains flat across three commitment tiers—meaning you choose your level of upfront savings without being locked into a dose schedule. If you need a higher dose, your monthly cost stays the same. PlexusDx operates in all 50 states and handles all shipping directly, so geographic location never restricts access to compounded GLP-1 medications.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need a doctor's referral to get GLP-1 prescribed through PlexusDx?
No referral is required. PlexusDx connects you directly with medical professionals who specialize in GLP-1 therapy through a telehealth consultation. Your current doctor does not need to refer you; you simply complete PlexusDx's intake process, and a provider evaluates whether GLP-1 is appropriate for your health profile.
How quickly will I see weight loss results on semaglutide?
Most patients experience noticeable appetite suppression within days, but meaningful weight loss typically appears after 4–8 weeks as the medication reaches steady state. Clinical trials show average weight loss of 5–10 pounds in the first month, accelerating to 15–22% total body weight loss over 68 weeks. Individual results vary based on genetics, diet, exercise, and adherence.
What is the difference between PlexusDx compounded medications and brand-name GLP-1 drugs?
PlexusDx medications are compounded from licensed 503A pharmacies, meaning they contain the same active pharmaceutical ingredients as brand-name versions but are prepared in smaller batches at lower cost. Compounded formulations are not FDA-approved but are legally manufactured under strict pharmacy regulations. Many patients achieve identical results at a fraction of the price.
Are there side effects I should know about before starting semaglutide?
Nausea, vomiting, constipation, and reduced appetite are common initially but typically resolve within 2–4 weeks. Serious side effects like pancreatitis or gallbladder issues are rare but require immediate medical attention. PlexusDx providers monitor for contraindications and side effects throughout your treatment, adjusting doses if needed to balance efficacy and tolerability.
What is the Precision Peptide Genetic Test and how does it improve my results?
This 99-dollar test analyzes 14 metabolic pathways and 150+ genetic variants to reveal your personalized peptide profile. Key insights include GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—variants affecting GLP-1 sensitivity, appetite control, and metabolic rate. These findings help PlexusDx providers predict whether semaglutide or tirzepatide will work best for your specific biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding GLP-1 Medications: Can You Take Wegovy and Ozempic Together?
Does Ozempic Help with Lymphedema? Understanding the Potential